1 Yao M,Shuin T,Misaki H,et al.Enhanced expression of cmyc and epidermal growth factor receptor(c-erbB-1) genein primary human renal cancer. Cancer Res, 1988, 48:6735. 2 Carpenter G, Cohen S. Epidermal growth factor-minireview. J Biol Chem, 1990, 265:7709. 3 Swahney N,Hall PA.Ki 67-structure,function,and new antibodies.J Pathol, 1992, 168:161. 4 Soini Y, Kamel D, Paakko P, et al. Aberrant accumulation of p53 associates with Ki67 and mitotic count in benign skin lesions. Br J Dermatol, 1994, 131:514. 5 Garcia RL,Coltrera MD,Gown AM.Analysis of proliferative grade using anti PCNA/cyclin monoclonal antibodies in fixed, embedded tissues:comparis on with flow cytometric analysis. Am J Pathol, 1989, 134:733. 6 Mcgregor JM, Yu CC-W, Dublin EA, et al. Aberrant expression of p53 tumour suppressor protein in non-melanoma skin cancer.Br J Dermatol, 1992, 127:463. 7 Stephenson TJ, Royds J, Silcocks PB, et al. Mutant p53 oncogene expression in keratoacanthoma and squamous cell carcinoma. Br J Dermatol, 1992, 127:566. |